Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 39 drug design and development PhD Projects, Programmes & Scholarships for UK Students

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a UK student


drug design and development PhD Projects, Programmes & Scholarships for UK Students

We have 39 drug design and development PhD Projects, Programmes & Scholarships for UK Students

Last chance to apply

Design and synthesis of a hybrid compound of RAR and VDR

The doctoral candidate (DC) will perform chemical research on the design and organic synthesis of hybrid compounds at the Medical University of Warsaw, Warsaw, Poland. Read more

Microfluidic Encapsulation of biologics into Nanomedicines

Progress in drug design has led to the development of new peptides, proteins, and drug molecules. However, the limited ability to deliver selectively these molecules at well-defined dosing regimens and without invoking drug-resistance remains a significant challenge. Read more
Last chance to apply

Predictive design of drug co-crystals through correlative studies of inter-molecular interactions

  Research Group: School of Chemical and Process Engineering
This interdisciplinary project presents an exciting opportunity for an ambitious scientist or engineer to work across the boundaries of chemistry, physics and engineering, with opportunities to develop a broad portfolio of skills. Read more

Fully funded PhD studentship in mechanisms of cancer heterogeneity and drug sensitivity

Treatment of cancer with drugs that cause DNA damage often leads to development of the drug tolerance. Recently, we uncovered a novel mechanism of such an adaptation that associates with active generation of hundreds of thousand mutations in chromosomes that prevent drug-triggered DNA damage. Read more

Novel subsurface Raman microscopy technologies to enable the development of next-generation drug and implant therapies

Start date. September 2024. Duration. 3.5 years. Raman spectroscopy is a powerful label-free analytical technique that measures the molecular composition of tissue by using light to excite molecular vibrations in the sample and generate Raman scattered photons. Read more

Small molecule cancer drug discovery targeting resistant disease.

Despite continuous advances in targeted cancer therapy in recent years, there remains a major challenge to combat drug resistance and poor levels of efficacy in areas of unmet medical need, such as advanced colorectal and breast cancer. Read more
Last chance to apply

Development of a highly innovative label-free & deep-learning based analysis method: Histoplasmonic Tissue Cytometry

The doctoral candidate (DC) will perform applied research in bioinformatics, i.e., the extraction of numerical values from biological samples, by engaging deep learning technologies to microscopic images with the aim to develop a novel solution for future clinical diagnostics of cancer. Read more
Last chance to apply

Preformulation study of RARγ and VDR hybrid compounds

The doctoral candidate (DC) will perform preformulation characterisation and development of formulation prototypes at Trinity College Dublin (TCD), Ireland. Read more

Combining CRISPR-screens and AI to Identify Novel Therapeutic Strategies to Target Cancer-Stroma Interactions

A fully funded PhD Studentship is available to work with Dr Angus Cameron, Reader in Cell Signalling and Tumour Cell Biology, Barts Cancer Institute at Queen Mary University London, Dr Otto Morris, Senior Biological Data Scientist at Exscientia, and Professor Pedro Cutillas, Professor of Cell Signalling and Proteomics, QMUL, Barts Cancer Institute at Queen Mary University London. Read more

Development of LA1011 for high affinity binding to Hsp90 for use towards healthy ageing in patients showing Alzheimer’s symptoms

  Research Group: Biochemistry
With 50 million global cases of Alzheimer’s disease (AD) and care costs of 1 trillion UK pounds (expected to triple by 2050), there is a pressing need to slow disease progression, sustain productive lives and reduce costs. Read more

Filtering Results